## Clinical Context This patient has Graves' disease with a desire for definitive treatment while preserving fertility. She has achieved biochemical control on PTU, making her an ideal candidate for thyroidectomy. ## Management Algorithm for Graves' Disease ```mermaid flowchart TD A[Graves' disease diagnosed]:::outcome --> B{Patient preference & factors?}:::decision B -->|Wants surgery| C[Achieve euthyroid state]:::action B -->|Wants RAI| D[RAI therapy]:::action B -->|Wants medical| E[Long-term ATD]:::action C --> F[Pretreatment with Lugol's iodine]:::action F --> G[Thyroidectomy]:::action G --> H[Lifelong levothyroxine]:::outcome ``` ## Key Point: **Preoperative preparation is essential before thyroid surgery in Graves' disease.** The patient must be rendered euthyroid using antithyroid drugs (PTU or methimazole) to prevent thyroid storm. Once biochemical control is achieved (TSH, free T4 in normal range), Lugol's iodine solution (10 drops TDS for 10 days) is given immediately before surgery to reduce gland vascularity and hormone release. ## High-Yield: - **Lugol's iodine mechanism:** Inhibits thyroid hormone release (not synthesis) and reduces blood flow to the gland, making surgery safer. - **Timing:** Iodine is given AFTER achieving euthyroid state, not before, because iodine alone cannot control hyperthyroidism and may paradoxically worsen it if given first. - **Surgery indications in Graves':** Large goiter causing compressive symptoms, failure of medical therapy, intolerance to ATDs, patient preference for definitive treatment, pregnancy (relative indication). ## Clinical Pearl: **This patient is an ideal surgical candidate** because: - She has achieved good biochemical control (prerequisite) - She is young and wishes to preserve fertility (RAI is relatively contraindicated) - She has a diffuse goiter without nodules (no suspicion of malignancy) - She is motivated for definitive treatment ## Operative Considerations - **Extent:** Subtotal thyroidectomy (leaving ~5 g of thyroid tissue) or total thyroidectomy with levothyroxine replacement. - **Recurrence risk:** Subtotal has ~5–10% recurrence; total has ~0% recurrence but requires lifelong replacement. - **Complications to monitor:** Recurrent laryngeal nerve injury (1–2%), superior laryngeal nerve injury, hypoparathyroidism (1–3%), thyroid storm (rare if properly prepared). 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.